Cargando…

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity

Detalles Bibliográficos
Autores principales:	Pulanić, Dražen, Desnica, Lana, Vrhovac, Radovan, Nemet, Damir, Wolff, Daniel, Greinix, Hildegard, Pavletic, Steven Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Croatian Medical Schools 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800321/ https://www.ncbi.nlm.nih.gov/pubmed/26935608 http://dx.doi.org/10.3325/cmj.2016.57.1

Ejemplares similares

Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters
por: Vukić, Tamara, et al.
Publicado: (2016)

Glycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?
por: Duraković, Nadira, et al.
Publicado: (2016)

Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
por: Perić, Zinaida, et al.
Publicado: (2016)

High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
por: Čeović, Romana, et al.
Publicado: (2016)

Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study
por: Prenc, Ema, et al.
Publicado: (2021)

Vitamin D levels and their associations with survival and major disease outcomes in a large cohort of patients with chronic graft-vs-host disease
por: Katić, Mašenjka, et al.
Publicado: (2016)

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
por: Lelas, Antonela, et al.
Publicado: (2021)

B regulatory cells and monocyte subpopulations in patients with chronic graft-vs-host disease
por: Babić, Antonija, et al.
Publicado: (2021)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

Chronic gvhd dictionary—eurograft cost action initiative consensus report
por: Zelić Kerep, Ana, et al.
Publicado: (2022)

Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic graft-versus-host disease: An international survey of the EBMT-NCI Chronic GVHD Task Force
por: Duarte, Rafael F., et al.
Publicado: (2013)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
por: Perovic, Vladimir, et al.
Publicado: (2022)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2020)

Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2021)

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
por: Schoemans, Helene M., et al.
Publicado: (2018)

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity
por: Grkovic, Lana, et al.
Publicado: (2011)

Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease
por: Zelic Kerep, Ana, et al.
Publicado: (2022)

The Impact of Achieving Complete Remission Prior to Allogeneic Stem Cell Transplantation on Progression-Free Survival in Hodgkin Lymphoma
por: Duraković, Nadira, et al.
Publicado: (2021)

Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
por: Pusic, Iskra, et al.
Publicado: (2019)

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial
por: Schoemans, Helene M., et al.
Publicado: (2018)

Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
por: Milosevic, Emina, et al.
Publicado: (2022)

Venous thromboembolism in Croatia – Croatian Cooperative Group for Hematologic Diseases (CROHEM) study
por: Pulanić, Dražen, et al.
Publicado: (2015)

National Institutes of Health–Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution
por: Lawitschka, Anita, et al.
Publicado: (2019)

Durable discontinuation of systemic therapy for chronic graft-versus-host disease: myth or reality?
por: Pavletic, Steven Z., et al.
Publicado: (2022)

Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021)

Complex interactions of cellular players in chronic Graft-versus-Host Disease
por: Gail, Laura Marie, et al.
Publicado: (2023)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023)

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective
por: Mariotti, Jacopo, et al.
Publicado: (2023)

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011)

GRAFT-VS.-HOST REACTION IN TISSUE CULTURE
por: Auerbach, Robert, et al.
Publicado: (1973)

Macrophage regulation of graft-vs-host disease
por: Hong, Ya-Qun, et al.
Publicado: (2020)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Ruxolitinib for the treatment of myelofibrosis: its clinical potential
por: Ostojic, Alen, et al.
Publicado: (2012)

Anthropometric and Laboratory Variables Related to Weight Loss—Comparison of Heart Failure Patients with Tumor Patients and Control Population
por: Letilovic, Tomislav, et al.
Publicado: (2017)

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Juric, Mateja Kralj, et al.
Publicado: (2017)

Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone
por: Hude, Ida, et al.
Publicado: (2018)

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
por: Kitko, Carrie L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jopkibm7gtehtq11co43e8slkc